Literature DB >> 3602221

Effects of ECT given two vs. three times weekly.

D A McAllister, M G Perri, R C Jordan, F P Rauscher, A Sattin.   

Abstract

The benefits and side effects of electroconvulsive therapy (ECT) given two vs. three times per week were examined in depressed inpatients. Twenty subjects were randomly assigned to one of two treatment conditions (unilateral ECT two or three times weekly). Examiners without knowledge of treatment condition rated depression and psychiatric status and administered tests of memory and visual-motor problem solving; subjects also provided self-ratings of depression. Measures were collected before treatment and 2 and 4 weeks after treatment began. Both schedules of treatment produced significant and equivalent improvements in psychiatric symptomatology, but visual memory impairment was significantly lower in the twice-weekly group.

Entities:  

Mesh:

Year:  1987        PMID: 3602221     DOI: 10.1016/0165-1781(87)90063-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Seizure duration over ect sessions: influence of spacing ects.

Authors:  N Janakiramaiah; K M Rao; J Praveen; B L Sujatha; B N Gangadhar; D K Subbakrishna
Journal:  Indian J Psychiatry       Date:  1992-04       Impact factor: 1.759

2.  Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy.

Authors:  R H Segman; B Shapira; M Gorfine; B Lerer
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

3.  Comparison of therapeutic efficacy of ect and imipramine : a randomized controlled trial.

Authors:  C P Selvan; P M Mayur; B N Gangadhar; N Janakiramaiah; D K Subbakrishna; N Murali
Journal:  Indian J Psychiatry       Date:  1999-07       Impact factor: 1.759

Review 4.  Frequency and Duration of Course of ECT Sessions: An Appraisal of Recent Evidence.

Authors:  Jagadisha Thirthalli; Shalini S Naik; Girish Kunigiri
Journal:  Indian J Psychol Med       Date:  2020-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.